Literature DB >> 24990260

Pre-clinical optical imaging and MRI for drug development in Alzheimer's disease.

Maarten Rotman1, Thomas J A Snoeks2, Louise van der Weerd3.   

Abstract

Optical and magnetic resonance imaging have the potential to be complementary non-invasive imaging modalities. Yet without advances in imaging technologies and contrast agents both have short-comings that cannot be ignored. In this review we demonstrate the pre-clinical use of the two imaging techniques in Alzheimer's disease, including examples from recent applications and discuss what is needed to improve their applicability for drug discovery.:
© 2011 Elsevier Ltd . All rights reserved.

Entities:  

Year:  2011        PMID: 24990260     DOI: 10.1016/j.ddtec.2011.11.005

Source DB:  PubMed          Journal:  Drug Discov Today Technol        ISSN: 1740-6749


  2 in total

Review 1.  Advance of molecular imaging technology and targeted imaging agent in imaging and therapy.

Authors:  Zhi-Yi Chen; Yi-Xiang Wang; Yan Lin; Jin-Shan Zhang; Feng Yang; Qiu-Lan Zhou; Yang-Ying Liao
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

Review 2.  PLGA-Based Drug Delivery Systems for Remotely Triggered Cancer Therapeutic and Diagnostic Applications.

Authors:  Xue Shen; Tingting Li; Xiaoxue Xie; Yi Feng; Zhongyuan Chen; Hong Yang; Chunhui Wu; Shengqi Deng; Yiyao Liu
Journal:  Front Bioeng Biotechnol       Date:  2020-05-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.